Moderna Inc (MRNA)

NASDAQ HEALTHCARE

$55.60 +2.53% RSI 46 Neutral Add Alert

Moving Averages

SMA 200

$33.65

Price above

Company Profile

Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$20.34B

P/E Ratio

None

EPS

$-7.14

Beta

1.336